Omega Life Science

Company Overview

Snapshot

Founded in January 2011, Omega Life Science operates with 1–10 employees. The company holds a patent for its technology, indicating a focus on proprietary innovation within the medical device sector.

Business overview

Omega Life Science specializes in developing medical devices for aerosol drug delivery, focusing on systemic, local, and CNS targeting. The company's core technology includes a proprietary inhaler platform, Alphazer, and tailor-made formulation technology. This platform produces submicron- to micron-sized droplets and submicron- to nano-sized dry particles for various pharmaceutical compounds. Omega Life Science serves the health tech and life sciences sectors, particularly within medical devices and drug delivery, with its handheld inhaler distributed with proprietary disposable drug cartridges.

Company Intelligence Q&A

What is Omega Life Science's primary focus?

Omega Life Science develops medical devices for aerosol drug delivery, targeting systemic, local, and central nervous system applications.

What is the Alphazer platform?

The Alphazer is Omega Life Science's proprietary inhaler platform designed to produce submicron- to micron-sized droplets and submicron- to nano-sized dry particles of pharmaceutical compounds for enhanced therapeutic effects.

What markets does Omega Life Science serve?

Omega Life Science operates within the global health tech and life sciences markets, specifically focusing on medical devices and drug delivery solutions.

What is the company's employee size?

Omega Life Science has 1–10 employees.

Is Omega Life Science a subsidiary?

Yes, Omega Life Science is a subsidiary of Nanosol Ltd.